Search
Please see below for a list of search results.
The Human Tissue Authority (HTA) has published licence fee levels for the 2020/21 business year.
The new licence fees come into effect from 1 April 2020, with an increase of 4% on the previous year’s fees.
Today the Human Tissue Authority (HTA) has published licence fee levels for the 2020/21 business year.
The new licence fees come into effect from 1 April 2020, with an increase of 4% on the previous year’s fees.
All establishments licensed under the Human Tissue Act 2004 and the Quality and Safety of Organs Intended for Transplantation Regulations 2012 must review their licensing records and complete a compliance update.
The information collected will be used to:
The Human Tissue Authority (HTA) had announced licence fee levels for the 2018/19 business year. These licence fees came into effect from April 2018 and was calculated on the same basis as 2017/18.
You can read the full sector breakdowns here.
In certain circumstances, the Human Tissue Act 2004 makes provision for a Licence Holder or Designated Individual or Licence Applicant to make Representations against a proposed licensing decision and / or make an Appeal to the HTA about a licensing decision.
The HTA licenses a number of activities relating to human tissue. We are also responsible for carrying out inspections to ensure licence conditions are being met. These activities are laid out in the Human Tissue Act and associated Regulations.
The activities licensed by the HTA are:
There are licensing exemptions in the HT Act 2004 and further specific exemptions in the HT Act 2004 (Ethical Approval, Exceptions from Licensing and Supply of Information about Transplants) Regulations 2006. These regulations came into force on 1 September 2006.